L3VLUP
ProSign in

CDRE in the 13F filings

Cadre HLDGS Inc · CUSIP 12763L105

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q2 2022
Quarter end
30 Jun 2022
the date the book describes
Filed
19 Aug 2022
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q1 2022 and Q2 2022; 0 listed it in both
Shares listed
150,555
combined, among listed positions
Reported value
$3.0m
combined, at the quarter end

Managers listing CDRE in Q2 2022

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2022, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
Walleye Capital LLC150,555$3.0m0.08%Newnew19 Aug 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

0123Q2 2022Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CDRE by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20221$3.0mn.a.n.a.
Q2 20241$1.0m10
Q3 20241$798k01
Q4 20241$15m10
Q1 20251$21m10
Q2 20251$23m00
Q3 20251$34m10
Q4 20251$34m117
Q1 20263$55m1110
Q2 20262$28m109

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CDRE and LLY →CDRE and JNJ →CDRE and VRTX →Choose a stock to compare with CDRE →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CDRE, latest filings →Back to the 13F Explorer →